Vamsi Kota

Associate Professor

  • 163 Citations
  • 7 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2010 2019

Filter
Review article
2019

Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation

Kota, V. & Atallah, E., Aug 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 8, p. 480-487 8 p.

Research output: Contribution to journalReview article

Open Access
Musculoskeletal Pain
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Therapeutics
Quality of Life
2018
7 Citations (Scopus)

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: Expert panel review

Cortes, J. E., Apperley, J. F., Deangelo, D. J., Deininger, M. W., Kota, V., Rousselot, P. & Gambacorti-Passerini, C., Dec 27 2018, In : Journal of Hematology and Oncology. 11, 1, 143.

Research output: Contribution to journalReview article

Leukemia, Myeloid, Chronic Phase
Therapeutics
Leukemia, Myeloid, Accelerated Phase
Diarrhea
Blast Crisis
6 Citations (Scopus)
Acute Promyelocytic Leukemia
Leukemia
Mortality
Population
Guidelines
2015
6 Citations (Scopus)

Volasertib for AML: Clinical use and patient consideration

Hao, Z. & Kota, V., Jul 17 2015, In : OncoTargets and Therapy. 8, p. 1761-1771 11 p., A205.

Research output: Contribution to journalReview article

Acute Myeloid Leukemia
Phase III Clinical Trials
Induction Chemotherapy
Cytarabine
Proxy
2014
5 Citations (Scopus)

Bosutinib: A third generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia

Hill, B. G., Kota, V. & Khoury, H. J., Jan 1 2014, In : Expert Review of Anticancer Therapy. 14, 7, p. 765-770 6 p.

Research output: Contribution to journalReview article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Therapeutics
Drug Prescriptions
Philadelphia Chromosome